Back to Search
PETER RAGONESI, MD
MD
Internal Medicine Physician
NPI: 1558349811IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine PhysicianPrimary
Internal Medicine
Code: 207R00000X
2007-00902(NC)
CMS Specialties
PrimaryINTERNAL MEDICINE
Education
OTHER
Class of 1990
Research & Publications (12)
Efficacy and safety of ezetimibe/simvastatin association on non-diabetic and diabetic patients with polygenic hypercholesterolemia or combined hyperlipidemia and previously intolerant to standard statin treatment.
PMID 19650249·J Clin Pharm Ther·2009
3-trial
Rosiglitazone therapy improves insulin resistance parameters in overweight and obese diabetic patients intolerant to metformin.
PMID 18375253·Arch Med Res·2008
4-observational
Metabolic effects of pioglitazone and rosiglitazone in patients with diabetes and metabolic syndrome treated with metformin.
PMID 17229249·Intern Med J·2007
4-observational
Metabolic effects of telmisartan and irbesartan in type 2 diabetic patients with metabolic syndrome treated with rosiglitazone.
PMID 17489878·J Clin Pharm Ther·2007
4-observational
Metformin-pioglitazone and metformin-rosiglitazone effects on non-conventional cardiovascular risk factors plasma level in type 2 diabetic patients with metabolic syndrome.
PMID 16882108·J Clin Pharm Ther·2006
4-observational
Telmisartan and irbesartan therapy in type 2 diabetic patients treated with rosiglitazone: effects on insulin-resistance, leptin and tumor necrosis factor-alpha.
PMID 17345784·Hypertens Res·2006
4-observational
Synergistic effect of doxazosin and acarbose in improving metabolic control in patients with impaired glucose tolerance.
PMID 17163286·Clin Drug Investig·2006
4-observational
Effects of 1 year of treatment with pioglitazone or rosiglitazone added to glimepiride on lipoprotein (a) and homocysteine concentrations in patients with type 2 diabetes mellitus and metabolic syndrome: a multicenter, randomized, double-blind, controlled clinical trial.
PMID 16861090·Clin Ther·2006
4-observational
Thiazolidinedione effects on blood pressure in diabetic patients with metabolic syndrome treated with glimepiride.
PMID 16555581·Hypertens Res·2005
3-trial
A comparison of the effects of pioglitazone and rosiglitazone combined with glimepiride on prothrombotic state in type 2 diabetic patients with the metabolic syndrome.
PMID 15955382·Diabetes Res Clin Pract·2005
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1381 WESTGATE CENTER DR
WINSTON SALEM, NC 27103 - Phone
- (336) 718-0100
Quick Facts
- NPI
- 1558349811
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 36
- Publications
- 12
Are you this provider?
Claim Your Profile